Press release: Ncardia Appoints Andy Holt as Chief Commercial Officer
Ncardia Secures $60+ Million to Expand iPSC Offerings
Press release: Cell & gene therapy accelerator to de-risk early stage research
Optimization of the Ncyte Astrocyte Kit
Advancing Lung Disease Detection, Prevention and Treatment
Ncardia and BlueRock: iPSC Cardiomyocyte Manufacturing Agreement
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
